Chia Seeds May Help Prevent Heart Disease, Diabetes And Cancer

Bristol Meyers May Have Jumped To The Top Of The Partners List

Chia seeds are very high in protein and lack the often high-fat content of animal food sources of protein. Eating chia seeds also offers you a healthy dose of omega-3 fatty acids and many important vitamins and minerals. Because chia seeds are rich in polyunsaturated and monounsaturated fats, including omega-3 and omega-6 fatty acids, consuming them may help lower the risk for heart disease and may also play an important role in preventing cancer. Chia seeds may also have a normalizing effect on insulin resistance, therefore helping with the prevention and management of type 2 diabetes. Dr. Oz writes that chia seeds are super because, like a superfruit, these seeds deliver the maximum amount of nutrients with a minimum amount of calories.
To visit the source content please visit the following website link – Chia seeds may help prevent heart disease, diabetes and cancer

Many with diabetes unaware of vision loss

He led the study at the Wilmer Eye Institute of Johns Hopkins University School of Medicine and Hospital in Baltimore. Diabetes commonly causes DME, which is a thickening of the eye’s retina. That change can be detected in an eye exam that includes dilation of the pupils. Left untreated, DME is likely to cause progressive vision loss. Degeneration of the retina in people with diabetes, known as diabetic retinopathy – which is often caused by DME – is the leading cause of blindness in the U.S., Bressler and his colleagues write in the journal JAMA Opthalmology. Many U.S. medical authorities recommend annual eye checks for diabetics to monitor early signs of vision problems, but many people with diabetes do not get the proper type or frequency of eye care (see Reuters Health story of December 10, 2013 here:
See Many with diabetes unaware of vision loss for the source write-up and associated media content

DEXTER: National Kidney Foundation brings Diabetes Prevention to Dexter area

Many assume because Bristol sold off their entire Type II drug portfolio to AstraZeneca they were completely exiting the diabetes market, but I would suggest they have now freed themselves to re-enter the competitive diabetes market as a specialty diabetes drug company selling a new and very exciting innovative specialty diabetes drug Afrezza. Offloading their share of an under performing diabetes drug portfolio they shared with Astrazenca rids them of any conflict of interest concerns Mannkind may have had about signing a partnership with them and it allows them to focus on introducing an innovative new diabetes drug that utilizes a novel inhaled delivery technology to the world. Diabetes although is a huge market it can and should be considered a specialty disease and Afrezza and Technosphere are definitely specialty products. A partnership between Bristol and Mannkind makes sense and it will be interesting to see if it happens. In addition Britstol Meyers is going to be flushed in new capital coming from the AstraZeneca deal.
See Bristol Meyers May Have Jumped To The Top Of The Partners List for the originating story and related media content

Diabetes: An opportunity for community paramedicine

A1C is also used to monitor glycemic control in patients with diabetes, often choosing targets of 7 percentor less in non-pregnant adults, 6.5 percentor less in select (higher risk for complications) populations, and 8% or less in patients with frequent episodes of hypoglycemia.[3] Familiarity with A1C values is important for paramedics. Use of a glucometer is now an EMT-level skill. As such, EMS needs to step up as a partner in health care and make a habit of checking capillary blood glucose on every patient with diabetes. Knowing the targets for proper control, measuring blood glucose at the time of treatment, and discussing the results with patients will help to reinforce the importance of good glycemic control. Community paramedic opportunities Contemporary treatment of diabetes involves anti-diabetes medications (oral and/or injected), diet, and blood glucose measurement, all of which take significant involvement on the part of patients. The education and support required are substantial but have been recognized to significantly reduce complications and therefore, are reimbursed by both Medicare and most health insurance payers.
See for the original article and relevant media content

“Given this, it is important that healthcare professionals make sure the annual conversation they have with people with diabetes about smoking as part of their care planning review is the start of a process of supporting smokers to give up. “Providing information about, and access to, the different ways to help people give up smoking is an important part of improving support for people with diabetes.” As well as calling on GPs to do more, the charity is urging people with diabetes who smoke to make a resolution to quit in 2014. There are about 3.8 million people with diabetes in the UK and one in six of them are smokers. The number of people with the disease is predicted to rise to 5 million by 2025. Professor Kevin Fenton, national director of health and wellbeing at Public Health England, said: “Public Health England supports all efforts to increase advice, support and education to those who wish to stop smoking.
For the source story please visit the following website –

Diabetes sufferers who smoke ‘not receiving proper treatment’

8 for prospective participants to learn more about the program, and the group starts meeting Jan. 15 at 11 am. The National Diabetes Prevention Program is a 16-week program, which helps those at high risk for developing type 2 diabetes to adopt and maintain a healthy lifestyle. Earlier in the year, the National Kidney Foundation of Michiganand Chelsea-Area Wellness Foundation offered the National Diabetes Prevention Program at the Chelsea Wellness Center and had great results, with 19 of the participants losing an overall average of 5 percent of their starting body weight. Staff Writer Sean Dalton can be reached at 734-246-0159 or . Follow him on Twitter and Tout @seankdalton.
To read the source source including any supplementary images or video, visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s